Transcranial Direct Current Stimulation clinical trials at UCLA
1 research study open to eligible people
Transcranial Direct Current Stimulation for Treatment of Acute Ischemic Stroke
open to eligible people ages 18 years and up
Many patients with acute ischemic stroke are ineligible for currently available standard treatments (clot-busting medication, also known as intravenous thrombolytic or mechanical removal of a clot), and many are non-responders, resulting in a low rate of excellent outcomes, which necessitates the development of novel therapies. In this study, investigators are testing a new treatment in which a weak electrical current will be applied via scalp electrodes to increase collateral blood flow to the brain and rescue the brain tissue at risk of injury. The primary aim is to find an optimal dose of this therapy that is both adequately safe and effective on imaging markers of brain tissue rescue.
Los Angeles, California and other locations
Last updated: